Table 4.
Comorbidities and Intraoperative Characteristics
| Transfemale Augmentation | Cisfemale Augmentation | P | |
|---|---|---|---|
| No. of patients | 280 | 1,080 | |
| Mean BMI ± SD (kg/m2) | 26.7 ± 5.6 | 22.3 ± 3.4 | <0.001 |
| Nonobese (BMI ≤ 29.9 kg/m2) | 206 (75.7%) | 1,027 (96.8%) | <0.001 |
| Obese (BMI ≥ 30.0 kg/m2) | 66 (24.3%) | 34 (3.2%) | |
| ASA classification | <0.001 | ||
| 1. No disturbance | 76 (27.1%) | 663 (61.4%) | |
| 2. Mild disturbance | 184 (65.7%) | 403 (37.3%) | |
| 3. Severe disturbance | 19 (6.8%) | 14 (1.3%) | |
| Location of procedure | <0.001 | ||
| Inpatient | 13 (4.6%) | 6 (0.6%) | |
| Outpatient | 267 (95.4%) | 1074 (99.4%) | |
| Smoking | <0.001 | ||
| Yes | 76 (27.1%) | 118 (10.9%) | |
| No | 204 (72.9%) | 962 (89.1%) | |
| Diabetes (type I or type II) | 12 (4.3%) | 10 (0.9%) | <0.001 |
| Hypertension | 29 (10.4%) | 34 (3.1%) | <0.001 |
| Steroid use | 2 (0.7%) | 1 (0.1%) | 0.048 |
| Operative time (min) | 95.9 ± 69.1 | 75.5 ± 49.6 | <0.001 |
| Length of stay (d) | 0.31 ± 1.4 | 0.11 ± 4.5 | 0.479 |
ASA, American Society of Anesthesiologists.